Market Place
Sourcing Support
Lipocine Announces Regulatory Pathway on Oral LPCN 1154 for PPD
15 Sep 2022 //
PRNEWSWIRE
Sage Therapeutics to halve its total workforce in radical cost-cutting move
08 Apr 2020 //
PHARMAFILE
Blasted by PhIII failure, a struggling Sage axes 340 staffers and bunkers down
08 Apr 2020 //
ENDPTS
Sage`s new drug starts slow, as Wall Street waits for depression data
14 Nov 2019 //
BIOPHARMADIVE
Sage strategy for postpartum depression drug Zulresso keys on patient support
01 Jul 2019 //
FIERCE PHARMA
FDA approves first drug specifically for postpartum depression
25 Mar 2019 //
IN-PHARMATECHNOLOGIST
FDA approves first treatment for postpartum depression
22 Mar 2019 //
FDA
Sage gets US approval for first postpartum depression therapy
21 Mar 2019 //
NIH
Sage raises $575m ahead of FDA review date for Zulresso
28 Feb 2019 //
PMLIVE
Sage Therapeutics Receives PDUFA Extension for ZULRESSO™ (brexanolone) Injection
21 Nov 2018 //
BUSINESSWIRE
Sage depression drug to cost between $20K and $35K, if approved
07 Nov 2018 //
BIOPHARMA DIVE
Sage appears set for a breakthrough FDA OK on postpartum depression drug
05 Nov 2018 //
ENDPTS
FDA panel recommends Sage`s postpartum depression treatment
03 Nov 2018 //
REUTERS
Sage Therapeutics Announces FDAAC Votes 17-1 in Support of ZULRESSO(brexanolone)
02 Nov 2018 //
BUSINESSWIRE
FDA suggests safety profile of Sage`s drug disqualifies from at-home infusions
30 Oct 2018 //
ENDPTS
Sage Announces Brexanolone in Postpartum Depression Trials Data Published
31 Aug 2018 //
BUSINESSWIRE
Sage files for an approval for its ‘breakthrough’ therapy for postpartum
23 Apr 2018 //
ENDPTS
Sage`s CEO: Have to weigh investor returns but price postpartum drug ‘fairly’
30 Mar 2018 //
CNBC
Does Sage`s Antidepressant Franchise Make It An Acquisition Target?
15 Jan 2018 //
SEEKINGALPHA
Sage Therapeutics Looks to File NDA for Postpartum Depression Treatment
12 Jan 2018 //
BIOSPACE
Likely FDA approval for postpartum depression drug pushes Sage therap stock 40%
10 Nov 2017 //
CNBC
Sage`s seizure drug fails key trial, shares slump
13 Sep 2017 //
REUTERS
Sage Therapeutics fuels, then dampens, its own M&A rumors
18 Feb 2017 //
FIERCE BIOTECH
Sage soars on small postpartum depression study results
12 Jul 2016 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.